SCHEMBL9856696

SCHEMBL9856696

CNCCC(Cc1ccccc1)c1ccccc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.43
HRH1 P35367 3/20 0.43
TAAR1 Q96RJ0 4/20 0.42
ATM Q13315 1/20 0.42
SLC6A4 P31645 6/20 0.40
SIGMAR1 Q99720 2/20 0.40
SLC18A2 Q05940 1/20 0.40
SLC6A2 P23975 2/20 0.39
SLC6A3 Q01959 2/20 0.39
KCNH2 Q12809 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HTT P42858 1/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR1A P08908 1/20 0.36
ADORA3 P0DMS8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9856543 0.81 SLC6A4 (0.40) HTR2AHRH1TAAR1SLC6A4SLC6A2
SCHEMBL19688012 0.78 TRPA1 (0.42) TAAR1SLC6A4SIGMAR1SLC18A2SLC6A2
SCHEMBL8384207 0.78 HTR2A (0.60) HTR2AHRH1TAAR1ATMSLC6A4
SCHEMBL9856421 0.73 HTR2A (0.44) HTR2AHRH1TAAR1ATMSLC6A4
SCHEMBL10446796 0.73 HTR2A (0.52) HTR2AHRH1TAAR1ATMSLC6A4
SCHEMBL2072466 0.73 CYP2D6 (0.65) HTR2ASLC6A4SLC6A2KCNH2CYP3A4
SCHEMBL9857056 0.72 HTR2A (0.51) HTR2AHRH1TAAR1SLC6A4SLC6A2
Sulfuric Acid SCHEMBL9856834 0.72 ALOX15 (0.42) SLC6A4SLC6A2CYP3A4CYP2D6L3MBTL1
SCHEMBL9856768 0.72 TAAR1 (0.54) HTR2AHRH1TAAR1ATMSLC6A4
SCHEMBL9856698 0.71 TAAR1 (0.42) HTR2AHRH1TAAR1SLC6A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996235-A Selectively inhibiting the uptake of serotonin and norepinephrine ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
EP-0318233-A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed